By Jefferey Jaxen

We are only seven short months into an emergency use, experimental vaccine rollout across the world. Seven months, yet governments are already warning that recipients of the jab are going to need booster shot vaccines due to decreasing effectiveness. 

That’s a problem. For everybody. But perhaps a bigger problem (for them) is that governments remain well short of their goals to convince populations to take the ‘first generation,’ shots…of now waning effectiveness. 

The booster rollout has dealt a fatal blow to an already shamelessly try-hard, multibillion dollar PR push to bully and coerce populations. 

To keep their populations calm and avoid disruption of vaccine confidence, most governments have been reassuring their citizens they had no inkling there would be a need for boosters. But on April 1st, Pfizer CEO Albert Bourla began laying the groundwork. 

“A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months, and then from there, there will be an annual revaccination…” said Bourla. 

The comment came after Johnson & Johnson CEO Alex Gorsky told CNBC in February that people may need to get vaccinated against Covid-19 annually, just like seasonal flu shots.

After signing a secret deal with Pfizer to enroll its entire population into a medical experiment, Israel’s aggressive vaccine push became the poster child for ‘successful’ compliance. Did their efforts work to eliminate Covid? Public health data from the Israeli Ministry of Health shows only 40% efficacy at halting transmission. 

On July 12th, Israel became the first country in the world to begin giving a Covid booster jab. The writing was on the wall. The initial shots had failed to stop Covid outbreaks in the Middle Eastern nation.

On July 8th, Pfizer announced that it was seeking U.S. authorization for a third [booster] dose of its COVID-19 vaccine. The news was an immediate detriment to an already struggling $1.5B U.S. vaccine public relations campaign, busy deploying celebrities and “trusted local officials.”  

The nearly 50% of American holdouts not coerced into joining the emergency use medical experiment were now left to ponder why they’d get a shot that’s not stopping transmission.   

The day after Pfizer’s announcement, U.S. public health agencies acted rapidly to pacify the population by putting out a joint statement from both the FDA and CDC promising no boosters…for now. 

It took roughly two weeks for that fleeting promise to evaporate into the media memory hole. The NY Times is now reporting Biden officials expect vulnerable Americans to need booster shots.

Even the NY Times is being forced to point out this “…is a sharp shift from just a few weeks ago, when the administration said it thought there was not enough evidence to back boosters yet.”

Then, chalking up another win for Science™, the NY Times admits, “a key official at the Centers for Disease Control and Prevention said the agency is exploring options to give patients with compromised immune systems third doses even before regulators broaden the emergency use authorization for coronavirus vaccines…”

Even colleges are doing a little public health ‘C.Y.A.’ The University of California’s updated ‘Student FAQ’ section on their website’s COVID-19 Vaccine Policy page now states: 

6. Is this a one-time mandate or will I be required to get boosters or annual shots? 

This is a permanent policy. Infectious disease experts anticipate that annual or more frequent boosters will be necessary, and receipt of boosters will be required, consistent with product labeling, in the same way that the initial vaccination is required by this policy and subject to the same exceptions and deferrals.

Meanwhile in Canada, Prime Minister Justin Trudeau calmly announced during a recent press conference, “We’ve reached a deal with Pfizer for 35 million booster doses for next year. And 30 million for the year after.” 

Trudeau continued, “This deal includes options to add 30 million doses in both 2022 and 2023. And an option for 60 million doses in 2024.” In the next breath, Trudeau stated “We’re in ongoing discussions with other manufacturers about their plans for booster shots.” What other manufacturers? Are all Covid vaccine makers readying boosters behind the scenes? 

Sustained protests are occurring in France after President Emmanuel Macron’s vaccine passport announcement. The country’s health agency tiptoed carefully around the booster subject. Health authority la Haute Autorité de la Santé (HAS) said “there is no need for the moment” to require most of the population to have a third dose of vaccine, “except for the most vulnerable and elderly,” given the “data available”.

In a June 30th announcement, the U.K.’s Joint Committee on Vaccination and Immunisation (JCVI) encouraged the NHS to prepare for an autumn booster rollout. Now, the Guardian is reporting that UK scientists are backing Covid boosters. When the rollout will happen, the U.K. government has provided no official statement.

Information and availability of effective therapeutics have been censored. A growing list of Covid-19 severe adverse events is being discovered at a rate of nearly one per month. Warnings about mass vaccination campaigns during an outbreak causing escape variants appear to have come to fruition. 

Why do public health experts still see more vaccination as the only option? To illustrate the height of this unscientific hysteria, a new study in the U.K. has just kicked off, attempting to treat patients suffering from so-called ‘long Covid’ – a condition which leaves sufferers battling symptoms for months after being infected. 

British scientists are now giving long Covid patients monthly doses of the Covid vaccine, in an effort to combat the chronic condition. The trial’s lead Dr. David Strain of the University of Exeter Medical School told The Mail: ’There’s no reason to believe that having one of these vaccines every month would be unsafe.’ Really?

How the booster push will be received in different countries remains to be seen. Although it’s ostensibly being rolled out for the vulnerable and immunocompromised, past experience suggests we should expect that the booster will quickly be mandated upon entire populations.